Moderate growth for Estonia's pharma market in first quarter
This article was originally published in Scrip
Executive Summary
Estonia's human pharmaceuticals market grew by 5% in the first quarter of 2010 to Eek738 million ($57.8 million) in wholesale prices compared with the same period last year, but was10% lower than the fourth quarter of 2009.